The role of photodynamic therapy in the esophagus.

Photodynamic therapy (PDT) is a drug and device therapy using photosensitizer drugs activated by laser light for mucosal ablation. Porfimer sodium PDT has been used extensively with proven long-term efficacy and durability for the ablation of Barrett esophagus and high-grade dysplasia. and early esophageal adenocarcinoma. However, continued use is hampered by an associated stricture risk and prolonged photosensitivity (4-6 weeks). Promising single-center European studies using other forms of PDT, such as aminolevulinic acid PDT, have not been replicated elsewhere, limiting the widespread use of other forms of PDT. Future use of PDT in esophageal disease depends on the development of improved dosimetry and patient selection to optimize treatment outcomes, while minimizing adverse events and complications.

[1]  Stephen G Bown,et al.  Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus. , 2005, Gastrointestinal endoscopy.

[2]  B. Overholt,et al.  Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. , 2009, Gastroenterology.

[3]  W S Payne,et al.  The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. , 1985, The New England journal of medicine.

[4]  B. Overholt,et al.  Photodynamic therapy of Barrett's esophagus: ablation of Barrett's mucosa and reduction in p53 protein expression after treatment. , 2008, Anticancer research.

[5]  Kenneth K Wang,et al.  Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. , 2001, Gastrointestinal endoscopy.

[6]  Prateek Sharma,et al.  Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma. , 2002 .

[7]  M. Mino‐Kenudson,et al.  Buried Barrett's Epithelium Following Photodynamic Therapy Shows Reduced Crypt Proliferation and Absence of DNA Content Abnormalities , 2008, The American Journal of Gastroenterology.

[8]  C J Stoddard,et al.  Endoscopic ablation of Barrett's oesophagus: a randomized‐controlled trial of photodynamic therapy vs. argon plasma coagulation , 2004, Alimentary pharmacology & therapeutics.

[9]  C. Foroulis,et al.  Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  B. Overholt,et al.  Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. , 1995, Gastrointestinal endoscopy.

[11]  B. Reid,et al.  p53-mutant clones and field effects in Barrett's esophagus. , 1999, Cancer research.

[12]  M. Wallace,et al.  Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer , 2004, Alimentary pharmacology & therapeutics.

[13]  Victor X D Yang,et al.  Doppler optical coherence tomography monitoring of microvascular tissue response during photodynamic therapy in an animal model of Barrett's esophagus. , 2007, Gastrointestinal endoscopy.

[14]  T. Stephenson,et al.  Aminolevulinic acid-induced photodynamic therapy: safe and effective ablation of dysplasia in Barrett's esophagus. , 2000, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[15]  V. Drory,et al.  Acute neuropathy mimicking porphyria induced by aminolevulinic acid during photodynamic therapy , 2005, Muscle & nerve.

[16]  H. Bergh On the evolution of some endoscopic light delivery systems for photodynamic therapy , 1998 .

[17]  A. May,et al.  A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia. , 1999, Endoscopy.

[18]  M. Reed,et al.  The History of Photodetection and Photodynamic Therapy¶ , 2001, Photochemistry and photobiology.

[19]  A. Zinsmeister,et al.  Prevalence of columnar-lined (Barrett's) esophagus , 1990 .

[20]  H. Wolfsen,et al.  Photodynamic Therapy for Barrett’s Esophagus and High Grade Dysplasia: Results of a Patient Satisfaction Survey , 2002, Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates.

[21]  Q. Peng,et al.  Photodynamic Therapy , 1988, Methods in Molecular Biology.

[22]  J. Luketich,et al.  Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients. , 2003, The Annals of thoracic surgery.

[23]  D. Kessel,et al.  Side effects and photosensitization of human tissues after aminolevulinic acid. , 1997, The Journal of surgical research.

[24]  Navtej S Buttar,et al.  Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus. , 2007, Gastrointestinal endoscopy.

[25]  E. G. Hahn,et al.  Photodynamic destruction of high grade dysplasia and early carcinoma of the esophagus after the oral administration of 5‐aminolevulinic acid , 1999, Cancer.

[26]  P. Siersema Photodynamic therapy for Barrett's esophagus: not yet ready for the premier league of endoscopic interventions. , 2005, Gastrointestinal endoscopy.

[27]  Hector Nava,et al.  Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy , 2005, Cancer Chemotherapy and Pharmacology.

[28]  Kenneth K Wang,et al.  Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. , 2007, Gastroenterology.

[29]  N. J. Brown,et al.  Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett’s esophagus , 2004, Surgical Endoscopy And Other Interventional Techniques.

[30]  T. Dougherty An update on photodynamic therapy applications. , 2002, Journal of clinical laser medicine & surgery.

[31]  M. Raimondo,et al.  Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. , 2002, Mayo Clinic proceedings.

[32]  D. Phillips,et al.  Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. , 1992, British Journal of Cancer.

[33]  L. Gossner,et al.  Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid , 1998 .

[34]  H. Wolfsen,et al.  Barrett's Esophagus Is Common in Older Men and Women Undergoing Screening Colonoscopy Regardless of Reflux Symptoms , 2006, The American Journal of Gastroenterology.

[35]  L. Gossner,et al.  Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. , 2005, Gastrointestinal endoscopy.

[36]  M. Rugge,et al.  The Veneto Region's Barrett's Oesophagus Registry: aims, methods, preliminary results. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[37]  J C Kennedy,et al.  Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.

[38]  Q. Peng,et al.  5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research , 1997, Photochemistry and photobiology.

[39]  E. Ellison,et al.  Photodynamic therapy for esophageal malignancy: a prospective twelve-year study. , 1996, The Annals of thoracic surgery.

[40]  Patricia L. Blount,et al.  p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. , 2001, Cancer research.

[41]  H. Wolfsen Carpe luz--seize the light: endoprevention of esophageal adenocarcinoma when using photodynamic therapy with porfimer sodium. , 2005, Gastrointestinal endoscopy.

[42]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[43]  Patricia L. Blount,et al.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. , 2000 .

[44]  Mary N. Phan,et al.  Optimization of light dosimetry for photodynamic therapy of Barrett's esophagus: efficacy vs. incidence of stricture after treatment , 2005 .

[45]  Masoud Panjehpour,et al.  Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. , 2003, Gastrointestinal endoscopy.

[46]  T. Stephenson,et al.  Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up. , 2003, Endoscopy.

[47]  Kenneth K Wang,et al.  Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. , 2000, Gastrointestinal endoscopy.

[48]  S. Bown,et al.  New photosensitizers for photodynamic therapy in gastroenterology. , 1999, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[49]  T. Stephenson,et al.  Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial , 2000, Gut.

[50]  H. Wolfsen,et al.  Photodynamic therapy for esophageal diseases: a clinical update. , 2003, Endoscopy.

[51]  B. Overholt,et al.  Light sources and delivery devices for photodynamic therapy in the gastrointestinal tract. , 2000, Gastrointestinal endoscopy clinics of North America.

[52]  N. Nishioka,et al.  Cost-Effectiveness of Photodynamic Therapy for Treatment of Barrett's Esophagus with High Grade Dysplasia , 2003, Digestive Diseases and Sciences.

[53]  A. Sonnenberg,et al.  Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.

[54]  M Dietel,et al.  Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study. , 2002, Endoscopy.

[55]  J. G. van den Tweel,et al.  Barrett's esophagus: development of dysplasia and adenocarcinoma. , 1989, Gastroenterology.

[56]  H. Barr,et al.  Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia. , 1999, Journal of photochemistry and photobiology. B, Biology.

[57]  B. Reid,et al.  Barrett's esophagus and esophageal adenocarcinoma. , 1991, Gastroenterology clinics of North America.

[58]  N. Nishioka,et al.  Patient predictors of esophageal stricture development after photodynamic therapy. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[59]  P. Monnier,et al.  Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy , 1996, Lasers in surgery and medicine.

[60]  Kenneth K Wang,et al.  Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[61]  Bergein F Overholt,et al.  Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.

[62]  H. Bergh,et al.  Rapid Communication: Stability of the Fluorescence Measurement of Foscan® in the Normal Human Oral Cavity as an Indicator of its Content in Early Cancers of the Esophagus and the Bronchi , 1999, Photochemistry and photobiology.

[63]  P. Fockens,et al.  Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection. , 2005, Endoscopy.

[64]  Kenneth K Wang,et al.  Current status of photodynamic therapy of Barrett's esophagus. , 1999, Gastrointestinal endoscopy.

[65]  Arjun G Yodh,et al.  Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model. , 2003, Journal of biomedical optics.

[66]  J. Tokar,et al.  Endoscopic therapy of dysplasia and early-stage cancers of the esophagus. , 2007, Seminars in radiation oncology.

[67]  H. Wolfsen Endoluminal therapy for Barrett's esophagus. , 2007, Gastrointestinal endoscopy clinics of North America.

[68]  H. S. de Bruijn,et al.  Monitoring In Situ Dosimetry and Protoporphyrin IX Fluorescence Photobleaching in the Normal Rat Esophagus During 5-Aminolevulinic Acid Photodynamic Therapy¶ , 2003 .

[69]  K. Ragunath,et al.  Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: A randomized prospective trial assessing efficacy and cost-effectiveness , 2005, Scandinavian journal of gastroenterology.

[70]  L. Gossner,et al.  Long Term Results of PDT for Early Neoplasia in Barrett's Esophagus , 2004 .

[71]  Thomas J. Dougherty,et al.  Basic principles of photodynamic therapy , 2001 .

[72]  J K Greenson,et al.  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.

[73]  Hiroshi Mashimo,et al.  Radiofrequency ablation in Barrett's esophagus with dysplasia. , 2009, The New England journal of medicine.

[74]  M. Guelrud,et al.  Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. , 2000, Gastrointestinal endoscopy.

[75]  J. Devière,et al.  Long-term Follow-Up and Factors Predictive of Recurrence in Barrett's Esophagus Treated by Argon Plasma Coagulation and Acid Suppression , 2002, Endoscopy.

[76]  G. Lapertosa,et al.  Barrett's esophagus: an update. , 2003, Critical reviews in oncology/hematology.

[77]  R. Sampliner Prevention of Adenocarcinoma by Reversing Barrett’s Esophagus with Mucosal Ablation , 2003, World Journal of Surgery.

[78]  H. Barr,et al.  Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX , 1996, The Lancet.

[79]  Kenneth K Wang,et al.  Photodynamic therapy in Barrett's esophagus. , 2003, Gastrointestinal endoscopy clinics of North America.

[80]  M. Zenker Argon plasma coagulation , 2008, GMS Krankenhaushygiene interdisziplinar.

[81]  B. Overholt,et al.  Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. , 1999, Gastrointestinal endoscopy.

[82]  D J Ballard,et al.  Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. , 1990, Gastroenterology.

[83]  M. V. Scott,et al.  Pilot Study on Light Dosimetry Variables for Photodynamic Therapy of Barrett's Esophagus with High-Grade Dysplasia , 2009, Clinical Cancer Research.

[84]  C. Hadjur,et al.  Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval. , 1997, British Journal of Cancer.

[85]  Herbert C Wolfsen,et al.  Present Status of Photodynamic Therapy for High-Grade Dysplasia in Barrett's Esophagus , 2005, Journal of clinical gastroenterology.

[86]  G. Bourg-Heckly,et al.  Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagus. , 2004, Gastrointestinal endoscopy.

[87]  A. Radu,et al.  Mucosal ablation with photodynamic therapy in the esophagus: optimization of light dosimetry in the sheep model. , 2003, Gastrointestinal endoscopy.

[88]  J. Luketich,et al.  Photodynamic Therapy with Curative Intent for Barrett’s Esophagus with High Grade Dysplasia and Superficial Esophageal Cancer , 2007, Annals of Surgical Oncology.

[89]  M Panjehpour,et al.  Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus. , 1993, Gastrointestinal endoscopy.

[90]  P. Grosjean,et al.  Localization of tetra(m-hydroxyphenyl)chlorin (Foscan) in human healthy tissues and squamous cell carcinomas of the upper aero-digestive tract, the esophagus and the bronchi: a fluorescence microscopy study. , 2001, Journal of photochemistry and photobiology. B, Biology.

[91]  H. Wolfsen Endoprevention of esophageal cancer: endoscopic ablation of Barrett’s metaplasia and dysplasia , 2005, Expert review of medical devices.

[92]  B. Overholt,et al.  Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation , 2000, American Journal of Gastroenterology.

[93]  J E Kaufman,et al.  Photoradiation therapy for the treatment of malignant tumors. , 1978, Cancer research.

[94]  H. Bergh,et al.  Optimization of the Diameter of a Radial Irradiation Device for Photodynamic Therapy in the Esophagus , 2002, Endoscopy.

[95]  B. Overholt,et al.  What is the best management strategy for high grade dysplasia in Barrett’s oesophagus? A cost effectiveness analysis , 2003, Gut.

[96]  B. Overholt,et al.  Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. , 2007, Gastrointestinal endoscopy.

[97]  N. Krasner,et al.  Photodynamic Therapy (PDT) for Oesophageal Dysplasia and Early Carcinoma with mTHPC (m-Tetrahydroxyphenyl Chlorin): A Preliminary Study , 2002, Lasers in Medical Science.

[98]  C. Mosse,et al.  How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolaevulinic acid for ablation of high-grade dysplasia in Barrett’s esophagus , 2008, Lasers in Medical Science.

[99]  H. Wolfsen,et al.  Photodynamic Therapy for Dysplastic Barrett's Esophagus and Mucosal Adenocarcinoma , 2004 .

[100]  L. Gossner,et al.  Curative treatment for high-grade intraepithelial neoplasia in Barrett's esophagus. , 2005, Endoscopy.

[101]  E. Steyerberg,et al.  5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised trial , 2004, Gut.

[102]  L. Gossner,et al.  Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques. , 2002, Endoscopy.

[103]  A. Zinsmeister,et al.  Correlation of histology with biomarker status after photodynamic therapy in Barrett esophagus , 2008, Cancer.